Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Cash & Equivalents (2018 - 2026)

Outset Medical has reported Cash & Equivalents over the past 8 years, most recently at $172.8 million for Q4 2025.

  • Quarterly Cash & Equivalents rose 39.34% to $172.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $172.8 million through Dec 2025, up 39.34% year-over-year, with the annual reading at $172.8 million for FY2025, 39.34% up from the prior year.
  • Cash & Equivalents was $172.8 million for Q4 2025 at Outset Medical, up from $36.4 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $274.3 million in Q2 2021 and troughed at $35.5 million in Q1 2024.
  • The 5-year median for Cash & Equivalents is $73.7 million (2022), against an average of $115.0 million.
  • Year-over-year, Cash & Equivalents crashed 85.59% in 2023 and then surged 441.61% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $215.7 million in 2021, then tumbled by 64.51% to $76.5 million in 2022, then fell by 6.13% to $71.8 million in 2023, then soared by 72.63% to $124.0 million in 2024, then soared by 39.34% to $172.8 million in 2025.
  • Per Business Quant, the three most recent readings for OM's Cash & Equivalents are $172.8 million (Q4 2025), $36.4 million (Q3 2025), and $39.6 million (Q2 2025).